Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

  • There is currently no data for KBT

PDMR Announcement

12 Jul 2019 16:41

RNS Number : 4387F
K3 Business Technology Group PLC
12 July 2019
 

 

AIM: KBT

12 July 2019

 

K3 Business Technology Group plc

("K3" or "Company")

PDMR Announcement

 

 

K3, which provides mission‐critical business software, cloud solutions and managed services, has received notification that Rob Price, CFO of the Company, has purchased 4,728 ordinary shares of 25p each in the capital of the Company ("Ordinary Shares") at a price of £2.11 per Ordinary Share (the "Purchase"). Following the Purchase Mr. Price is now interested in 54,728 Ordinary Share representing 0.127% of the total voting rights of the Company.

 

The Company makes the below announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014) in respect of the Purchase:

Enquiries:

 K3 Business Technology Group plc

Adalsteinn Valdimarsson, CEO

Rob Price, CFO

T: 0161 876 4498

finnCap Limited (NOMAD & Broker)

 

Julian Blunt/James Thompson (Corporate Finance)

Camille Gochez (Corporate Broking)

 

T: 020 7220 0500

KTZ Communications

Katie Tzouliadis/Dan Mahoney

T: 020 3178 6378

 

 

 

 

1.

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Robert Price

2.

Reason for notification

b)

Position / status

executive director (CFO)

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

K3 Business Technology Group plc

c)

LEI

213800QOJ9OF2AV81748

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

 

Identification code

 

ordinary shares of 25p each

 

 

GB00B00P6061

b)

Nature of the transaction

Acquisition of ordinary shares of 25p each

 

 

c)

Price(s) and volume(s)

 Volume: 4,728

Price: 211p per Ordinary Share

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

9 July 2019

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBUGDRLXBBGCD
Date   Source Headline
1st Apr 20207:00 amRNSLoan Funding Secured and Update on Subsidiary
24th Mar 20207:00 amRNSDelay to Final Results
21st Feb 202011:28 amRNSHolding(s) in Company
18th Feb 20203:10 pmRNSDirector/PDMR Shareholding
17th Feb 202012:32 pmRNSBoard Appointment
6th Feb 20204:13 pmRNSBoard Changes
28th Oct 20196:15 pmRNSPDMR Announcement
24th Oct 20192:09 pmRNSDirector/PDMR Shareholding
22nd Oct 20192:00 pmRNSPrice Monitoring Extension
22nd Oct 20197:00 amRNSTrading update
12th Jul 20194:41 pmRNSPDMR Announcement
9th Jul 20197:00 amRNSInterim Results
18th Jun 20197:00 amRNSTrading Update
23rd May 20198:48 amRNSPDMR Announcement
22nd May 20192:05 pmRNSResult of AGM
19th Mar 20197:00 amRNSFinal Results
8th Feb 20192:42 pmRNSPDMR Dealings
22nd Jan 20191:06 pmRNSHolding(s) in Company
17th Dec 20187:00 amRNSTrading Update
29th Oct 20183:05 pmRNSHolding(s) in Company
20th Aug 20186:15 pmRNSHolding(s) in Company
9th Jul 20187:00 amRNSInterim Results
13th Jun 201810:44 amRNSHolding(s) in Company
11th Jun 20187:00 amRNSContracts Wins
7th Jun 20187:00 amRNSCapital Markets Afternoon & Notice of Results
30th May 201811:02 amRNSResult of AGM
30th May 20187:00 amRNSAGM Statement
6th Apr 20183:40 pmRNSHolding(s) in Company
5th Apr 20184:36 pmRNSPDMR Dealings
27th Mar 20187:00 amRNSFinal Results (17 months)
5th Mar 20183:48 pmRNSHolding(s) in Company
5th Jan 20189:50 amRNSHolding(s) in Company
27th Dec 20172:19 pmRNSDirector/PDMR Shareholding
12th Dec 20177:00 amRNSTrading Update
27th Sep 20177:00 amRNSSecond Interim Results
26th Sep 201711:52 amRNSHolding(s) in Company
18th Sep 201711:17 amRNSHolding(s) in Company
8th Aug 20173:55 pmRNSHolding(s) in Company
6th Jul 20175:25 pmRNSHolding(s) in Company
6th Jul 201710:48 amRNSPDMR Shareholding
6th Jul 20179:05 amRNSHolding(s) in Company
5th Jul 20171:17 pmRNSHolding(s) in Company
4th Jul 201711:41 amRNSReplacement:Result of General Meeting
4th Jul 201711:11 amRNSSIP Announcement
4th Jul 201711:06 amRNSResult of General Meeting
4th Jul 201710:36 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSSigning of Facility Amendment Agreement
30th Jun 20177:00 amRNSResult of Open Offer
12th Jun 201712:58 pmRNSResults of Proposed Placing
12th Jun 20177:00 amRNSFundraising & Board Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.